First-in-human, Single Ascending Dose Study of CEL383 in Healthy Adult Subjects
Clinical trial NCT05901883 · COMPLETED
Trial details
- NCT number
- NCT05901883
- Sponsor
- Celsius Therapeutics, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-06-20
- Primary completion
- 2024-01-17
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.